2m 2m 2m 2m 2m 2m 2m
Intellia Therape (NTLA)
NASDAQ
$10.85+$0.17 (+1.59%)
Price as of Aug 03, 2026 7:34 AM EDT- $1.5BMarket Cap
- -7.05%1-Year Change
- BiotechnologyIndustry
Intellia Therape (NTLA)
$10.85+$0.17 (+1.59%)
Earnings Score
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 30.61% | ||
12-Month Momentum | 48.11% | ||
3-Month Risk Adjusted Momentum | 82.40% | ||
12-Month Risk Adjusted Momentum | 50.32% |
True Yield
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 2 |